Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants

Clinical trial NCT07072611 · RECRUITING

Trial details

NCT number: NCT07072611
Sponsor: Noxopharm Limited
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Cutaneous Lupus Erythematosus

Start date: 2025-07-14
Primary completion: 2026-02-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.